Clinical-stage immunology company developing ANV419.
#BioPharma
Developing therapies for viral diseases.
#BioPharma
Research and development of targeted therapeutics; acquired by Merck.
#BioPharma
Develops angiogram-based FFR (FFRangio) for coronary catheterization.
#Medical Devices
Developed immunotherapies for cancer; lead agent CM-24; acquired by Merck in July 2015.
#BioPharma
Developing an ingestible pill for colorectal cancer screening that avoids bowel prep.
#Medical Devices
Applies computational cell-level models to advance pharmaceutical R&D.
#Digital Health
Developing antisense drugs for Centronuclear Myopathies (CNM).
#BioPharma
Develops compounds for genetic diseases caused by nonsense mutations.
#BioPharma
European ADC company; lead program targets Nectin-4; acquired by Lilly in 2023.
#BioPharma
Developing cell-based therapies for immune tolerance; lead program in graft-versus-host disease.
#BioPharma
Develops non-viral gene therapy treatments for ophthalmology.
#BioPharma
Develops medical devices for treatment of corneal edema.
#Medical Devices
Identifies tumor-specific driver mutations using a functional assay.
#BioPharma
Developing an accommodating intraocular lens for post-cataract surgery.
#MedTech
Developing selective ROCK2 inhibitors; lead asset GV101 for fibrotic and autoimmune indications.
#BioPharma
Developing mitochondrial replaced cells therapy for mitochondrial disorders.
#BioPharma
Clinical-stage company focused on selective oral immunology therapies.
#BioPharma
Developing small molecule TRPV3 inhibitors for dermatological conditions.
#BioPharma
Focused on treatments for rare muscle diseases; lead program for FOP.
#BioPharma
Developed engineered autologous T-cell therapies; sold to Gilead.
#BioPharma
Development-stage company commercializing improved versions of CNS treatments.
#BioPharma
Developing topical oxymetazoline for cosmetic eye lifts.
#BioPharma
Developing GeneRide gene therapy platform for rare diseases.
#BioPharma
Developing LUT014, a topical B-Raf inhibitor to manage EGFR inhibitor side effects.
#BioPharma
Develops therapies for oncology and rare diseases.
#BioPharma
Drug discovery in cancer metabolism using computational biology and metabolomics.
#BioPharma
Developing targeted cancer therapies.
#BioPharma
Developing drug-device bioconvergence platform to deliver drugs to the uterus with a 3D carrier.
#MedTech
Develops medicines for addiction and drug overdose.
#BioPharma
Developing ophthalmic therapies for retinal vascular disorders.
#Debt
Develops personalized T cell therapies targeting neo-antigens.
#BioPharma
Develops radiopharmaceuticals using camelid-derived single-domain antibodies.
#BioPharma
Developed gene therapies for Parkinson’s and other neurodegenerative diseases; acquired by Lilly.
#BioPharma
RNA therapeutics platform focused on rare inherited retinal diseases.
#BioPharma
Manufactures recombinant therapeutic proteins using a plant cell-based expression system (ProCellEx).
#BioPharma
Clinical-stage company developing a drug for local fat reduction (obesity-related indications).
#BioPharma
Develops a robotic exoskeleton system for individuals with lower limb disabilities.
#MedTech
Developing RyR1/2 modulators for cardiac, musculoskeletal and neurological disorders.
#BioPharma
Rare disease company focused on CNS treatments.
#BioPharma
Develops next-generation antibody-drug conjugates for immuno-oncology.
#BioPharma
Late-stage biopharmaceutical company focused on rare diseases.
#BioPharma
Ophthalmic biotech focused on treatments for Stargardt’s disease.
#BioPharma
Developing small molecule therapeutics for autoimmune diseases.
#BioPharma
Developing Artificial Ostomy Sphincter (Stimatix GI AOS) products.
#MedTech
Novel gene therapy pipeline targeting rare disorders.
#Biopharma
Telemedicine platform for outcome prediction and clinical intervention in diabetics.
#Mobile Health
Develops microbiome-based treatments for eating disorders and weight management.
#BioPharma
Clinical-stage specialty pharmaceutical company focused on sustained-release formulations for uro-oncology.
#BioPharma
Developed a catheter-implanted miniature valve to reduce cardiac chamber pressure in certain patients.
#MedTech
Founded 2019; developing therapies for neurodegenerative diseases, including programs targeting GCase for Parkinson’s disease.
#BioPharma
Develops technologies for coronary and peripheral revascularization surgeries.
#Medical Devices
Commercial-stage company developing next-generation vaccines for infectious diseases and immuno-oncology.
#BioPharma